Quarterly Results • Search Archive

Morepen Laboratories Limited
Results, Financials & Updates

Follow Morepen Laboratories Limited results and financial updates in one company page: latest revenue or income, profit, margins, quarter comparisons, what changed and detailed Nivata Results deep dives.

2 published deep dives 2 quarters 2 sectors

Company Overview

Morepen Laboratories Limited: latest results and financials

Latest covered quarterQ2 FY27NSE: MOREPENLAB
Revenue from operations₹746.50 CrReported in the latest covered quarter
Profit after tax₹88.89 CrReported in the latest covered quarter
Margin—Latest available reported margin
About the business in Nivata's latest coverage

Morepen Laboratories Limited is an Indian pharmaceutical and healthcare enterprise with more than four decades of operating experience spanning active pharmaceutical ingredients (APIs), contract development and manufacturing operations (CDMO), medical devices, and formulation products. The company serves customers across more than 90 countries, leveraging its scientific and manufacturing foundations in regulated and emerging markets.

Quarter History

Morepen Laboratories reported trend

Each row comes from the corresponding Nivata Results brief. Reporting scope can differ between quarters; open the quarter for full context.

QuarterRevenue / incomePATMargin
Q2 FY27Consolidated₹746.50 Cr₹88.89 Cr—Open ↗
Q1 FY27Consolidated₹583.13 Cr₹53.27 Cr—Open ↗
← All quarterly results

Quarter history

Morepen Laboratories Limited Results & Financials

Latest Nivata coverage: Q2 FY27 · revenue ₹746.50 Cr · PAT ₹88.89 Cr.